These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 6190339)

  • 21. Beta-thromboglobulin content in megakaryocytes of patients with myeloproliferative diseases.
    Grossi A; Vannucchi AM; Rafanelli D; Filimberti E; Rossi Ferrini P
    Thromb Res; 1986 Aug; 43(3):367-74. PubMed ID: 2426823
    [No Abstract]   [Full Text] [Related]  

  • 22. Platelet defects in the myeloproliferative disorders.
    Inceman S; Tangün Y
    Ann N Y Acad Sci; 1972 Oct; 201():251-61. PubMed ID: 4509685
    [No Abstract]   [Full Text] [Related]  

  • 23. Serum erythropoietin (ESF) levels and erythroid progenitors (CFU-Es) of patients with chronic myeloproliferative disorders.
    Fukushima Y; Miura I; Takahashi T; Fukuda M; Yoshida K; Yamaguchi A; Miura AB
    Tohoku J Exp Med; 1984 Apr; 142(4):399-407. PubMed ID: 6588639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tissue culture of bone marrow. 3. Myelostimulatory factors in serum of patients with myeloproliferative diseases.
    Reisner EH
    Cancer; 1967 Oct; 20(10):1679-88. PubMed ID: 5234302
    [No Abstract]   [Full Text] [Related]  

  • 25. Beta 2-microglobulin in chronic lymphocytic leukaemia.
    Simonsson B; Wibell L; Nilsson K
    Scand J Haematol; 1980 Feb; 24(2):174-80. PubMed ID: 6154964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Density distribution and size of megakaryocytes in inflammatory reactions of the bone marrow (myelitis) and chronic myeloproliferative diseases.
    Thiele J; Holgado S; Choritz H; Georgii A
    Scand J Haematol; 1983 Oct; 31(4):329-41. PubMed ID: 6578591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical significance of beta-thromboglobulin in patients with high platelet count.
    Fabris F; Randi ML; Casonato A; Dal Bo Zanon R; Bonvicini P; Girolami A
    Acta Haematol; 1984; 71(1):32-8. PubMed ID: 6197855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Morphological erythroblast and erythrocyte abnormalities during the course of proliferative diseases of the myeloid tissue].
    Muratore R; Foa R; Follana R; Bayle J; Olmer J
    Nouv Rev Fr Hematol; 1973; 13(3):339-44. PubMed ID: 4270587
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of aspirin on platelet 5-hydroxytryptamine and beta-thromboglobulin plasma levels in patients with myeloproliferative diseases.
    Viero P; Cortelazzo S; Bassan R; Barbui T
    Thromb Haemost; 1982 Oct; 48(2):125-6. PubMed ID: 6184841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma fibronectin in idiopathic myelofibrosis and related chronic myeloproliferative disorders.
    Hasselbalch H; Clemmensen I
    Scand J Clin Lab Invest; 1987 Sep; 47(5):429-33. PubMed ID: 3477850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simultaneous study of platelets and phagocytes in myeloproliferative disorders.
    Laharrague PF; Corberand JX; Fillola G; Boneu BP; Pris JF
    Biomed Pharmacother; 1984; 38(9-10):462-5. PubMed ID: 6597727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between the concentration of neutrophils and monocytes in venous blood.
    Bain BJ; Wickramasinghe SN
    Acta Haematol; 1976; 55(2):89-94. PubMed ID: 816147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spontaneous platelet aggregation in myeloproliferative disorders. A preliminary study.
    Barbui T; Battista R; Dini E
    Acta Haematol; 1973; 50(1):25-9. PubMed ID: 4200801
    [No Abstract]   [Full Text] [Related]  

  • 34. Studies on the phagocytic activity of neutrophilic leukocytes.
    Brandt L
    Scand J Haematol Suppl; 1967; 2():1-126. PubMed ID: 5243720
    [No Abstract]   [Full Text] [Related]  

  • 35. [Blood coagulation and fibrinolysis in chronic myeloproliferative syndromes].
    Takahashi K; Shibata A
    Rinsho Ketsueki; 1980 May; 21(5):577-86. PubMed ID: 6997548
    [No Abstract]   [Full Text] [Related]  

  • 36. Template bleeding time and clinical hemorrhage in myeloproliferative disease.
    Murphy S; Davis JL; Walsh PN; Gardner FH
    Arch Intern Med; 1978 Aug; 138(8):1251-3. PubMed ID: 277084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitamin B 12 -binding protein of leukocytes as a possible major source of the third vitamin B 12 -binding protein of serum.
    Carmel R; Herbert V
    Blood; 1972 Oct; 40(4):542-9. PubMed ID: 4116417
    [No Abstract]   [Full Text] [Related]  

  • 38. Enzymes of glutathione synthesis in patients with myeloproliferative disorders.
    Blume KG; Paniker NV; Beutler E
    Clin Chim Acta; 1973 May; 45(3):281-5. PubMed ID: 4513517
    [No Abstract]   [Full Text] [Related]  

  • 39. Neutrophils with ring-shaped nuclei in myeloproliferative disease.
    Langenhuijsen MM
    Br J Haematol; 1984 Oct; 58(2):227-30. PubMed ID: 6591944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Reduced glutathione (GSH) in erythrocytes in myeloproliferative diseases].
    Benöhr HC; Tigges FJ; Waller HD
    Verh Dtsch Ges Inn Med; 1973; 79():461-3. PubMed ID: 4790261
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.